These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10358724)

  • 1. The results of radiotherapy for T1 glottic cancers; influence of radiation beam energy.
    Yamamoto M; Joja I; Takemoto M; Kuroda M; Hiraki Y
    Acta Med Okayama; 1999 Apr; 53(2):91-4. PubMed ID: 10358724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
    Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.
    Sommat K; Yit NL; Kwok LL
    Laryngoscope; 2017 May; 127(5):1061-1067. PubMed ID: 27237064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy.
    Ahmed WA; Suzuki K; Imaeda Y; Horibe Y
    Auris Nasus Larynx; 2008 Jun; 35(2):213-9. PubMed ID: 17996416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients.
    Marshak G; Brenner B; Shvero J; Shapira J; Ophir D; Hochman I; Marshak G; Sulkes A; Rakowsky E
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1009-13. PubMed ID: 10192348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.
    Tong CC; Au KH; Ngan RK; Chow SM; Cheung FY; Fu YT; Au JS; Law SC
    Radiat Oncol; 2011 May; 6():53. PubMed ID: 21600025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
    Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
    Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or cobalt-60 gamma-rays.
    Hayakawa K; Mitsuhashi N; Tamaki Y; Takahashi M; Honjo J; Kamei T; Koyama I; Niibe H
    Radiat Med; 1992; 10(5):199-205. PubMed ID: 1438927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
    Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
    Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.
    Parsons JT; Greene BD; Speer TW; Kirkpatrick SA; Barhorst DB; Yanckowitz T
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):953-9. PubMed ID: 11429223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation.
    Dinshaw KA; Sharma V
    Indian J Cancer; 1990 Sep; 27(3):143-53. PubMed ID: 2090566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of radiotherapy in early glottic carcinoma.
    Smee RI; Meagher NS; Williams JR; Broadley K; Bridger GP
    Head Neck; 2010 Jul; 32(7):850-9. PubMed ID: 20029987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy.
    Oie Y; Itoh Y; Kawamura M; Takase Y; Murao T; Ishihara S; Nomoto Y; Hirasawa N; Asano A; Yamakawa K; Ito J; Kinoshita F; Naganawa S
    Nagoya J Med Sci; 2021 Nov; 83(4):811-825. PubMed ID: 34916724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.